Literature DB >> 33297399

HIV-1C env and gag Variation in the Cerebrospinal Fluid and Plasma of Patients with HIV-Associated Cryptococcal Meningitis in Botswana.

Nametso Kelentse1,2, Sikhulile Moyo1,3, Mompati L Mogwele1,4, Doreen Ditshwanelo1, Baitshepi Mokaleng1,2, Natasha O Moraka1,5, Kwana Lechiile1,6, Tshepo B Leeme1,6, David S Lawrence1,7, Rosemary Musonda1,3, Ishmael Kasvosve2, Thomas S Harrison8, Joseph N Jarvis1,6,7,9, Simani Gaseitsiwe1,3.   

Abstract

HIV-1 compartmentalization in reservoir sites remains a barrier to complete HIV eradication. It is unclear whether there is variation in HIV-1 env and gag between cerebrospinal fluid (CSF) and plasma of individuals with HIV-associated cryptococcal meningitis (CM). We compared HIV-1 env characteristics and the gag cytotoxic T-lymphocyte (CTL) escape mutations from CSF and plasma samples. Employing population-based Sanger sequencing, we sequenced HIV-1 env from CSF of 25 patients and plasma of 26 patients. For gag, 15 CSF and 21 plasma samples were successfully sequenced. Of these, 18 and 9 were paired env and gag CSF/plasma samples, respectively. There was no statistically significant difference in the proportion of CCR5-using strains in the CSF and plasma, (p = 0.50). Discordant CSF/plasma virus co-receptor use was found in 2/18 pairs (11.1%). The polymorphisms in the HIV-1 V3 loop were concordant between the two compartments. From the HIV-1 gag sequences, three pairs had discordant CTL escape mutations in three different epitopes of the nine analyzed. These findings suggest little variation in the HIV-1 env between plasma and CSF and that the CCR5-using strains predominate in both compartments. HIV-1 gag CTL escape mutations also displayed little variation in CSF and plasma suggesting similar CTL selective pressure.

Entities:  

Keywords:  Botswana; CCR5; CXCR4; cerebrospinal fluid; co-receptor; cryptococcal meningitis; escape mutations; human immunodeficiency virus (HIV); plasma

Mesh:

Substances:

Year:  2020        PMID: 33297399      PMCID: PMC7762280          DOI: 10.3390/v12121404

Source DB:  PubMed          Journal:  Viruses        ISSN: 1999-4915            Impact factor:   5.048


  50 in total

1.  Evolutionary indicators of human immunodeficiency virus type 1 reservoirs and compartments.

Authors:  David C Nickle; Mark A Jensen; Daniel Shriner; Scott J Brodie; Lisa M Frenkel; John E Mittler; James I Mullins
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

2.  HIV-1 tropism testing and clinical management of CCR5 antagonists: Quebec review and recommendations.

Authors:  Cécile Tremblay; Isabelle Hardy; Richard Lalonde; Benoit Trottier; Irina Tsarevsky; Louis-Philippe Vézina; Michel Roger; Mark Wainberg; Jean-Guy Baril
Journal:  Can J Infect Dis Med Microbiol       Date:  2013       Impact factor: 2.471

3.  HIV coreceptor tropism in paired plasma, peripheral blood mononuclear cell, and cerebrospinal fluid isolates from antiretroviral-naïve subjects.

Authors:  S G Parisi; C Andreoni; L Sarmati; C Boldrin; A R Buonomini; S Andreis; R Scaggiante; M Cruciani; O Bosco; V Manfrin; G d'Ettorre; C Mengoli; V Vullo; G Palù; M Andreoni
Journal:  J Clin Microbiol       Date:  2011-03-02       Impact factor: 5.948

4.  Replication-competent simian immunodeficiency virus (SIV) Gag escape mutations archived in latent reservoirs during antiretroviral treatment of SIV-infected macaques.

Authors:  Suzanne E Queen; Brian M Mears; Kathleen M Kelly; Jamie L Dorsey; Zhaohao Liao; Jason B Dinoso; Lucio Gama; Robert J Adams; M Christine Zink; Janice E Clements; Stephen J Kent; Joseph L Mankowski
Journal:  J Virol       Date:  2011-06-29       Impact factor: 5.103

5.  Frequency of coreceptor tropism in PBMC samples from HIV-1 recently infected blood donors by massively parallel sequencing: the REDS II study.

Authors:  Rodrigo Pessôa; Ester C Sabino; Sabri S Sanabani
Journal:  Virol J       Date:  2015-05-14       Impact factor: 4.099

6.  Frequent CXCR4 tropism of HIV-1 subtype A and CRF02_AG during late-stage disease--indication of an evolving epidemic in West Africa.

Authors:  Joakim Esbjörnsson; Fredrik Månsson; Wilma Martínez-Arias; Elzbieta Vincic; Antonio J Biague; Zacarias J da Silva; Eva Maria Fenyö; Hans Norrgren; Patrik Medstrand
Journal:  Retrovirology       Date:  2010-03-22       Impact factor: 4.602

7.  HIV evolution: CTL escape mutation and reversion after transmission.

Authors:  A J Leslie; K J Pfafferott; P Chetty; R Draenert; M M Addo; M Feeney; Y Tang; E C Holmes; T Allen; J G Prado; M Altfeld; C Brander; C Dixon; D Ramduth; P Jeena; S A Thomas; A St John; T A Roach; B Kupfer; G Luzzi; A Edwards; G Taylor; H Lyall; G Tudor-Williams; V Novelli; J Martinez-Picado; P Kiepiela; B D Walker; P J R Goulder
Journal:  Nat Med       Date:  2004-02-08       Impact factor: 53.440

8.  The CCR5 and CXCR4 coreceptors are both used by human immunodeficiency virus type 1 primary isolates from subtype C.

Authors:  Tonie Cilliers; Jabulani Nhlapo; Mia Coetzer; Dragana Orlovic; Thomas Ketas; William C Olson; John P Moore; Alexandra Trkola; Lynn Morris
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

9.  Incidence of symptomatic CSF viral escape in HIV infected patients receiving atazanavir/ritonavir (ATV/r)-containing ART: a tertiary care cohort in western India.

Authors:  Atul K Patel; Ketan K Patel; Swati Gohel; Ambuj Kumar; Scott Letendre
Journal:  J Neurovirol       Date:  2018-04-24       Impact factor: 2.643

Review 10.  The HIV glycan shield as a target for broadly neutralizing antibodies.

Authors:  Katie J Doores
Journal:  FEBS J       Date:  2015-10-23       Impact factor: 5.542

View more
  1 in total

1.  ViMIC: a database of human disease-related virus mutations, integration sites and cis-effects.

Authors:  Ying Wang; Yuantao Tong; Zeyu Zhang; Rongbin Zheng; Danqi Huang; Jinxuan Yang; Hui Zong; Fanglin Tan; Yujia Xie; Honglian Huang; Xiaoyan Zhang
Journal:  Nucleic Acids Res       Date:  2022-01-07       Impact factor: 16.971

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.